RECIST Calculator – Response Evaluation Criteria in Solid Tumors

RECIST Calculator (v1.1)

Standardized assessment of tumor response for clinical trials and oncology practice.

Baseline Sum of Diameters (mm)

The sum of the longest diameters of all target lesions at start of treatment.

Please enter a valid baseline value.

Nadir Sum of Diameters (mm)

The smallest sum of diameters recorded since treatment started (includes baseline).

Nadir cannot be negative.

Current Sum of Diameters (mm)

The sum of diameters at the current follow-up assessment.

Current sum must be a number.

New Lesions or Progression of Non-Target Lesions?

Presence of any new malignant lesion defines Progressive Disease.

BEST RESPONSE CATEGORY
Enter Data

Comparison: Baseline vs Nadir vs Current

% Change from Baseline

–

% Change from Nadir

–

Absolute Change from Nadir (mm)

–

Formula: PD = +20% from Nadir & +5mm absolute; PR = -30% from Baseline; CR = 0mm.

What is a RECIST Calculator?

The RECIST calculator is a specialized clinical tool used by oncologists and radiologists to standardize the assessment of tumor burden in cancer patients. RECIST stands for Response Evaluation Criteria in Solid Tumors. It provides a reliable objective framework to determine if a patient’s cancer is shrinking, staying the same, or growing during treatment.

Clinicians use the RECIST calculator primarily in clinical trials to ensure that data across different hospitals and countries can be compared accurately. It eliminates subjective “eyeballing” of scans and replaces it with rigorous mathematical criteria. While RECIST 1.1 is the most common version used today, the core principles of using the sum of diameters (SLD) remain the primary metric for tracking therapeutic efficacy.

Common misconceptions include the idea that every tumor must be measured. In reality, the RECIST calculator focuses on “Target Lesions”—a maximum of five representative tumors—while others are tracked qualitatively as non-target lesions.

RECIST Calculator Formula and Mathematical Explanation

The RECIST calculator utilizes the Sum of Longest Diameters (SLD) to calculate percentage changes. The criteria for progression are specifically designed to account for measurement variability.

Variable	Meaning	Unit	Typical Range
Baseline SLD	Initial sum of target diameters before treatment	mm	10mm – 250mm
Nadir SLD	Smallest sum recorded since baseline (inclusive)	mm	0mm – Baseline
Current SLD	Sum of diameters at the latest scan	mm	0mm – 500mm
% Change Baseline	((Current – Baseline) / Baseline) × 100	%	-100% to +1000%

The four response categories defined by the RECIST calculator are:

Complete Response (CR): Disappearance of all target lesions.
Partial Response (PR): At least a 30% decrease in SLD compared to Baseline.
Progressive Disease (PD): At least a 20% increase in SLD compared to Nadir (and ≥5mm absolute increase).
Stable Disease (SD): Neither PR nor PD.

Practical Examples (Real-World Use Cases)

Example 1: Partial Response
A patient starts with a Baseline SLD of 100mm. After two cycles of chemotherapy, the RECIST calculator shows a current SLD of 65mm. Since (65-100)/100 = -35%, this exceeds the 30% threshold for a Partial Response (PR).

Example 2: Progressive Disease
A patient has a Baseline of 50mm. At the first follow-up, the SLD drops to 40mm (this is the new Nadir). At the second follow-up, the SLD increases to 49mm. The RECIST calculator logic: (49-40)/40 = +22.5% increase from nadir. Because the increase is >20% and the absolute increase (9mm) is >5mm, this is classified as Progressive Disease (PD).

How to Use This RECIST Calculator

Input Baseline SLD: Enter the sum of diameters from the pre-treatment scan.
Enter Nadir SLD: This is critical. Look at all previous scans during this treatment. Pick the lowest sum recorded. For the first follow-up, Nadir equals Baseline.
Input Current SLD: Enter the sum from your latest imaging report.
Check for New Lesions: If the radiologist noted a new lesion, select “Yes”. This overrides other values to indicate PD.
Review Results: The RECIST calculator will immediately highlight the category and show the % change.

Key Factors That Affect RECIST Calculator Results

Understanding the nuances of the RECIST calculator is essential for accurate clinical decision-making:

Lymph Node Measurement: Unlike other tumors (measured by longest diameter), lymph nodes are measured by their short axis. Nodes must be ≥15mm to be target lesions.
Nadir Importance: Progression is always calculated against the best response seen so far (nadir), not just the baseline. This prevents “stable” disease from slowly growing unnoticed.
The 5mm Rule: To call PD, the increase must not only be 20% but also at least 5mm in absolute terms to account for scan-to-scan variability.
New Lesions: The RECIST calculator treats any new definitive lesion as progression, regardless of what the original target lesions are doing.
Target vs. Non-Target: Only 5 lesions total (2 per organ) are used in the calculation, but progression of non-target lesions can still trigger PD.
Skeletal Lesions: Bone metastases are often “non-measurable” unless they have a soft tissue component ≥10mm.

Frequently Asked Questions (FAQ)

Q: What happens if a lesion becomes too small to measure?
A: If it’s still present, a default value of 5mm is often used, or it is recorded as “too small to measure” (TSTM).

Q: Can I use this RECIST calculator for brain tumors?
A: Typically, RANO criteria are used for brain tumors, though RECIST can be used for solid metastatic brain lesions.

Q: What is the difference between RECIST 1.0 and 1.1?
A: 1.1 reduced the number of target lesions from 10 to 5 and clarified lymph node measurement and PET scan usage.

Q: Why do we use the short axis for lymph nodes?
A: The short axis is more predictive of malignancy and less prone to measurement error than the long axis for nodes.

Q: Does the RECIST calculator work for immunotherapy?
A: Immunotherapy often uses iRECIST, which accounts for “pseudoprogression” where tumors temporarily grow before shrinking.

Q: Is a 25% decrease a Partial Response?
A: No, the RECIST calculator requires a minimum 30% decrease for PR status.

Q: If SLD increases by 15% from Nadir, is that PD?
A: No, it is considered Stable Disease (SD) because it hasn’t reached the 20% threshold.

Q: Can a patient have CR if lymph nodes are 8mm?
A: Yes. In RECIST 1.1, lymph nodes must be <10mm (short axis) to be considered a complete response.

Related Tools and Internal Resources

Oncology Staging Guide – Learn about TNM staging alongside the RECIST calculator.
Chemotherapy Dose Calculator – Calculate BSA and carboplatin dosing for your patients.
Survival Probability Tool – Use statistical models to estimate outcomes after RECIST assessment.
Radiology Reference Manual – Guide for measuring complex lesions for the RECIST calculator.
Clinical Trial Phase Finder – Match RECIST outcomes with eligible Phase II/III trials.
iRECIST vs RECIST 1.1 Comparison – A deep dive into immunotherapy-specific response criteria.